Oral Cancer Treatment Market Expected to Reach $2.7 Billion by 2030-Allied Market Research

According to a new report published by Allied Market Research, titled, “Oral Cancer Treatment Market by drug type, age group and distribution channel: global opportunity analysis and industry forecast, 2021–2030," the global Oral Cancer Treatment Market was valued at $1.7 billion in 2020 and is projected to reach $2.7 billion by 2030 registering a CAGR of 4.80% from 2021 to 2030.

Oral cancers are part of a group of cancers commonly referred to as head and neck cancers, and of all head and neck cancers, they comprise about 85% of that category. Furthermore, oral cancer accounts for approximately three 3% of all cancers diagnosed annually in the U.S, or about 53,000 new cases each year. In addition, oral cancer most often occurs in people over the age of 40 and affects more than twice as many men as women. Most oral cancers are related to tobacco use, alcohol use (or both), or infection by the human papilloma virus (HPV).

Growing prevalence of oral or mouth cancer globally is a major factor fostering the growth of the market. Rise in expenditure on the development of healthcare infrastructure, increase in consumption of tobacco products such as cigarettes, cigars, pipes and chewing tobacco and upsurge in the special designation from regulatory authorities are other factors also raising the growth of the market. On the other hand, increasing personal disposable income coupled with rising prevalence of papillomavirus infection is other indirect cause that will create lucrative growth opportunities for market. However, lack of awareness about the oral cancer in the backward and underdeveloped areas will hamper the market growth.

The global oral cancer treatment market is segmented into drug type, age group, distribution channel, and region. Depending on treatment, the market is bifurcated into chemotherapy, immunotherapy, targeted therapy. The age group segment is further categorized into 30-49, 50-69 and 70<. By end user, it is fragmented into hospital pharmacies, drug stores & retail pharmacies, online stores. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Severe COVID‐19 represents viral pneumonia from severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, which leads to acute respiratory distress syndrome. Its appearances can be viewed as a combination of the two processes that is viral pneumonia and acute respiratory distress syndrome. SARS‐CoV‐2 represents an ongoing worldwide threat, as this virus family has the potential to mutate and infect non‐immune population. Furthermore, Owing to the well-known major risk factors, oral cancer is considered a preventable disease and moreover, due to easy accessibility, it can be detected in early stages. Yet, majority of oral cancer cases in the developing countries are diagnosed in advanced stages, resulting in increased morbidity and mortality of oral cancer. Generally, dentists play a pivotal role in the early detection of oral cancer through opportunistic screening when a patient presents in a dental practice for routine care and by rapid referral of suspicious lesions. In the time of COVID-19, nevertheless, the whole world being in lockdown, and dental clinics are closed. Therefore, opportunities for screening the oral cavity might be significantly disrupted, and consequently diagnosis of malignant and/or potentially malignant lesions might be delayed, a matter that inevitably leads to a missed diagnosis of oral cancer or, at best, diagnosis later on but at a late stage.

On the basis of drug therapy, the chemotherapy segment was the major shareholder 2020. In oral cancer, it's usually used after surgery to prevent the cancer returning. In throat cancer, it's often the first treatment to be given, in combination with chemotherapy medicine (chemoradiotherapy). The treatment is usually given every day over the course of 6 six weeks, depending on the size of the cancer and how far it has spread.

Key Findings Of The Study

• By treatment, the radiation therapy segment garnered the largest share in the global market in 2020.
• On the basis of age group, the 50-69 was the major shareholder in 2020, and expected to remain dominant throughout the forecast period.
• Depending on end user, the hospitals dominated the global market in 2020, and is anticipated to continue this trend during the forecast period.
• Region wise, Asia-Pacific is expected to exhibit highest CAGR of 5.40% during the forecast period.

Increase in demand for surgical therapies for the treatment of oral cancer and rise in investment by governments in research & development to improve treatments boost the global market. North America dominated the global market in 2019 and this trend is projected to continue during the forecast period owing to the rising health care investments in the region and prevalence of oral cancer. The oral cancer treatment market in Asia-Pacific is anticipated to expand at a rapid pace during the forecast period. Rise in tobacco usage, increase in smoking, rapidly expanding health care industry, growing patient population, and high unmet needs are expected to drive the oral cancer treatment market in the region. Further, favorable government policies and rise in disposal income are anticipated to propel the oral cancer treatment market in the region during the forecast period.